Education
About Us
Working with TipRanks
Follow Us
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 258.00M | $ 117.00M | $ 112.00M | $ 383.00M | $ 77.52M |
| Operating Income | $ -330.00M | $ -340.00M | $ -280.00M | $ 54.00M | $ -124.23M |
| EBITDA | $ -263.00M | $ -285.00M | $ -258.00M | $ 59.00M | $ -120.00M |
| Net Income | $ -283.00M | $ -307.00M | $ -267.00M | $ 53.00M | $ -123.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 1.15B | $ 1.09B | $ 1.34B | $ 1.59B | $ 772.29M |
| Total Debt | $ 48.00M | $ 0.00 | $ 0.00 | $ 116.89M | $ 15.24M |
| Net Debt | $ -930.00M | $ -759.00M | $ -1.01B | $ -382.11M | $ -713.40M |
| Total Liabilities | $ 665.00M | $ 633.00M | $ 688.00M | $ 750.00M | $ 269.99M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -170.00M | $ -306.00M | $ 432.00M | $ -282.00M | $ 108.73M |
| Operating Cash Flow | $ -170.00M | $ -306.00M | $ 438.00M | $ -256.00M | $ 111.78M |
| Investing Cash Flow | |||||
| Financing Cash Flow |